168 related articles for article (PubMed ID: 35844707)
1. Lactic acidosis and hypoglycemia as markers of disease progression of multiple myeloma: A case report.
Ziegler C; Volkov L; Marnai R; Courte G; Cravoisy A; Conrad M; Nace L; Melone A; Perrot A; Gibot S
EJHaem; 2021 Aug; 2(3):539-544. PubMed ID: 35844707
[No Abstract] [Full Text] [Related]
2. Severe Lactic Acidosis and Hypoglycemia Associated With Burkitt Lymphoma and the Warburg Effect.
Khanal P; Pokharel A; Bastola S
Cureus; 2024 May; 16(5):e60985. PubMed ID: 38916019
[TBL] [Abstract][Full Text] [Related]
3. Type B lactic acidosis associated with diffuse large B-cell lymphoma and the Warburg effect.
Wang C; Lv Z; Zhang Y
J Int Med Res; 2022 Jan; 50(1):3000605211067749. PubMed ID: 34986706
[TBL] [Abstract][Full Text] [Related]
4. Lactic Acidosis and Hypoglycemia in a Patient with Gastric Diffuse Large B-Cell Lymphoma due to the Warburg Effect.
Hamada T; Kaku T; Mitsu S; Morita Y; Ohno N; Yamaguchi H
Case Rep Oncol; 2020; 13(2):1047-1052. PubMed ID: 33082747
[TBL] [Abstract][Full Text] [Related]
5. Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study.
Cavo M; Gay F; Beksac M; Pantani L; Petrucci MT; Dimopoulos MA; Dozza L; van der Holt B; Zweegman S; Oliva S; van der Velden VHJ; Zamagni E; Palumbo GA; Patriarca F; Montefusco V; Galli M; Maisnar V; Gamberi B; Hansson M; Belotti A; Pour L; Ypma P; Grasso M; Croockewit A; Ballanti S; Offidani M; Vincelli ID; Zambello R; Liberati AM; Andersen NF; Broijl A; Troia R; Pascarella A; Benevolo G; Levin MD; Bos G; Ludwig H; Aquino S; Morelli AM; Wu KL; Boersma R; Hajek R; Durian M; von dem Borne PA; Caravita di Toritto T; Zander T; Driessen C; Specchia G; Waage A; Gimsing P; Mellqvist UH; van Marwijk Kooy M; Minnema M; Mandigers C; Cafro AM; Palmas A; Carvalho S; Spencer A; Boccadoro M; Sonneveld P
Lancet Haematol; 2020 Jun; 7(6):e456-e468. PubMed ID: 32359506
[TBL] [Abstract][Full Text] [Related]
6. Safety and Effectiveness of Weekly Carfilzomib, Lenalidomide, Dexamethasone, and Daratumumab Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma: The MANHATTAN Nonrandomized Clinical Trial.
Landgren O; Hultcrantz M; Diamond B; Lesokhin AM; Mailankody S; Hassoun H; Tan C; Shah UA; Lu SX; Salcedo M; Werner K; Rispoli J; Caple J; Sams A; Verducci D; Jones K; Concepcion I; Ciardello A; Chansakul A; Schlossman J; Tavitian E; Shekarkhand T; Harrison A; Piacentini C; Rustad EH; Yellapantula V; Maclaughlan K; Maura F; Landau HJ; Scordo M; Chung DJ; Shah G; Lahoud OB; Thoren K; Murata K; Ramanathan L; Arcila ME; Ho C; Roshal M; Dogan A; Derkach A; Giralt SA; Korde N
JAMA Oncol; 2021 Jun; 7(6):862-868. PubMed ID: 33856405
[TBL] [Abstract][Full Text] [Related]
7. Carfilzomib with cyclophosphamide and dexamethasone or lenalidomide and dexamethasone plus autologous transplantation or carfilzomib plus lenalidomide and dexamethasone, followed by maintenance with carfilzomib plus lenalidomide or lenalidomide alone for patients with newly diagnosed multiple myeloma (FORTE): a randomised, open-label, phase 2 trial.
Gay F; Musto P; Rota-Scalabrini D; Bertamini L; Belotti A; Galli M; Offidani M; Zamagni E; Ledda A; Grasso M; Ballanti S; Spadano A; Cea M; Patriarca F; D'Agostino M; Capra A; Giuliani N; de Fabritiis P; Aquino S; Palmas A; Gamberi B; Zambello R; Petrucci MT; Corradini P; Cavo M; Boccadoro M
Lancet Oncol; 2021 Dec; 22(12):1705-1720. PubMed ID: 34774221
[TBL] [Abstract][Full Text] [Related]
8. Multiple myeloma associated with lactic acidosis.
Ustun C; Fall P; Szerlip HM; Jillella A; Hendricks L; Burgess R; Dainer P
Leuk Lymphoma; 2002 Dec; 43(12):2395-7. PubMed ID: 12613530
[TBL] [Abstract][Full Text] [Related]
9. Refractory Lactic Acidosis and Hypoglycemia in a Patient With Metastatic Esophageal Cancer Due to the Warburg Effect.
Karki U; Thapa B; Niroula S; Poudel S; Stender M; Khanal D
Cureus; 2023 Jun; 15(6):e40563. PubMed ID: 37465784
[TBL] [Abstract][Full Text] [Related]
10. "Hyper-warburgism," a cause of asymptomatic hypoglycemia with lactic acidosis in a patient with non-Hodgkin's lymphoma.
Elhomsy GC; Eranki V; Albert SG; Fesler MJ; Parker SM; Michael AG; Griffing GT
J Clin Endocrinol Metab; 2012 Dec; 97(12):4311-6. PubMed ID: 23055548
[TBL] [Abstract][Full Text] [Related]
11. Renal recovery following daratumumab, lenalidomide, and dexamethasone therapy in a patient with newly diagnosed dialysis-dependent multiple myeloma.
Mizuno S; Kitayama C; Mashiko S; Sanada S
CEN Case Rep; 2022 May; 11(2):265-268. PubMed ID: 34817845
[TBL] [Abstract][Full Text] [Related]
12. The Warburg Effect as a Type B Lactic Acidosis in a Patient With Acute Myeloid Leukemia: A Diagnostic Challenge for Clinicians.
Brault C; Zerbib Y; Delette C; Marc J; Gruson B; Marolleau JP; Maizel J
Front Oncol; 2018; 8():232. PubMed ID: 29974036
[TBL] [Abstract][Full Text] [Related]
13. EMA Review of Daratumumab (Darzalex) for the Treatment of Adult Patients Newly Diagnosed with Multiple Myeloma.
Michaleas S; Penninga E; Hovgaard D; Dalseg AM; Rosso A; Sarac SB; Jimenez JC; Fernández LL; Fernández CP; Mangas-SanJuan V; Garcia I; Payares-Herrera C; Sancho-López A; Enzmann H; de Castro Lopes Silva MSS; Duarte S; Pignatti F
Oncologist; 2020 Dec; 25(12):1067-1074. PubMed ID: 33026700
[TBL] [Abstract][Full Text] [Related]
14. Atypical Presentation of Burkitt Lymphoma With Isolated Peritoneal Involvement and Association With Refractory Type B Lactic Acidosis and Hypoglycemia Secondary to the Warburg Effect.
Abbas AK; Osman AY
Cureus; 2023 Feb; 15(2):e35521. PubMed ID: 37007395
[TBL] [Abstract][Full Text] [Related]
15. Warburg effect mimicking inborn errors of metabolism in childhood hematologic malignancies: A case-based systematic review.
Permtawee K; Tengsujaritkul M; Choed-Amphai C; Chanthong S; Mankhemthong K; Sathitsamitphong L; Natesirinilkul R; Charoenkwan P
World J Clin Pediatr; 2023 Dec; 12(5):350-358. PubMed ID: 38178939
[TBL] [Abstract][Full Text] [Related]
16. Non-islet-cell tumor hypoglycemia and lactic acidosis in a child with congenital HIV and Burkitt's lymphoma.
Rastogi MV; Desai N; Quintos JB
J Pediatr Endocrinol Metab; 2008 Aug; 21(8):805-10. PubMed ID: 18825882
[TBL] [Abstract][Full Text] [Related]
17. FDA Approval Summary: Daratumumab for Treatment of Multiple Myeloma After One Prior Therapy.
Bhatnagar V; Gormley NJ; Luo L; Shen YL; Sridhara R; Subramaniam S; Shen G; Ma L; Shord S; Goldberg KB; Farrell AT; McKee AE; Pazdur R
Oncologist; 2017 Nov; 22(11):1347-1353. PubMed ID: 28904172
[TBL] [Abstract][Full Text] [Related]
18. Type B lactic acidosis associated with multiple myeloma.
Sia P; Plumb TJ; Fillaus JA
Am J Kidney Dis; 2013 Sep; 62(3):633-7. PubMed ID: 23759296
[TBL] [Abstract][Full Text] [Related]
19. Lenalidomide plus dexamethasone versus observation in patients with high-risk smouldering multiple myeloma (QuiRedex): long-term follow-up of a randomised, controlled, phase 3 trial.
Mateos MV; Hernández MT; Giraldo P; de la Rubia J; de Arriba F; Corral LL; Rosiñol L; Paiva B; Palomera L; Bargay J; Oriol A; Prosper F; López J; Arguiñano JM; Quintana N; García JL; Bladé J; Lahuerta JJ; Miguel JS
Lancet Oncol; 2016 Aug; 17(8):1127-1136. PubMed ID: 27402145
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial.
Gay F; Oliva S; Petrucci MT; Conticello C; Catalano L; Corradini P; Siniscalchi A; Magarotto V; Pour L; Carella A; Malfitano A; Petrò D; Evangelista A; Spada S; Pescosta N; Omedè P; Campbell P; Liberati AM; Offidani M; Ria R; Pulini S; Patriarca F; Hajek R; Spencer A; Boccadoro M; Palumbo A
Lancet Oncol; 2015 Dec; 16(16):1617-29. PubMed ID: 26596670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
